13F Pro

SEC Form 4 reporting owner

Winningham Rick E

Winningham Rick E has filed 15 Form 4 transactions reported between February 20, 2026 and September 23, 2026, as CHIEF EXECUTIVE OFFICER of Theravance Biopharma, Inc. and Director of Jazz Pharmaceuticals plc.

Name as filed: Winningham Rick E

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$662K
1 lines
Companies
2
with Form 4 filings
Latest transaction
Sep 23, 2026
transaction date

Roles and reported holdings

  • TBPHTheravance Biopharma, Inc.
    Feb 20, 2026 – Sep 23, 2026

    CHIEF EXECUTIVE OFFICER

    Held directly1,611,022 sh as of Aug 20, 2026 · Form 4
  • JAZZJazz Pharmaceuticals plc
    May 22, 2026 – Aug 31, 2026

    Director

    Held directly9,466 sh as of Aug 31, 2026 · Form 4

    24 months: $662K sold

Transaction history

All 15 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 23, 2026TBPHCHIEF EXECUTIVE OFFICERDisposition to issuerCode D · direct515,000—Form 4
Sep 23, 2026TBPHCHIEF EXECUTIVE OFFICERDisposition to issuerCode D · indirect92,567—Form 4
Sep 23, 2026TBPHCHIEF EXECUTIVE OFFICERDisposition to issuerCode D · indirect23,400—Form 4
Sep 23, 2026TBPHCHIEF EXECUTIVE OFFICERDisposition to issuerCode D · direct76,875—Form 4
Sep 23, 2026TBPHCHIEF EXECUTIVE OFFICERDisposition to issuerCode D · direct151,875—Form 4
Sep 23, 2026TBPHCHIEF EXECUTIVE OFFICERDisposition to issuerCode D · direct1,382,272—Form 4
Aug 31, 2026JAZZDirectorShares withheld for tax or exercise priceCode F · direct14$3K@ $244.64Form 4
Aug 31, 2026JAZZDirectorShares withheld for tax or exercise priceCode F · direct1,692$408K@ $241.39Form 4
Aug 20, 2026TBPHCHIEF EXECUTIVE OFFICERShares withheld for tax or exercise priceCode F · direct20,034$340K@ $16.95Form 4
Aug 5, 2026JAZZDirectorGrant or awardCode A · direct1,605—Form 4
May 22, 2026JAZZDirectorOpen-market saleCode S · direct2,741$662K@ $241.57Form 4
May 22, 2026JAZZDirectorOption exerciseCode M · direct3,415$472K@ $138.08Form 4
May 20, 2026TBPHCHIEF EXECUTIVE OFFICERShares withheld for tax or exercise priceCode F · direct20,038$332K@ $16.55Form 4
Apr 1, 2026TBPHCHIEF EXECUTIVE OFFICERGrant or awardCode A · direct75,000—Form 4
Feb 20, 2026TBPHCHIEF EXECUTIVE OFFICERShares withheld for tax or exercise priceCode F · direct74,975$1.5M@ $19.66Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.